N/A N=42 Other

Addressing Arm Non-use by Encouraging Idle-time Activity During Early Recovery From Stroke

Stroke · Exercise

Bottom Line

View on ClinicalTrials.gov: NCT05900999 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jan 2026

Primary outcome: Primary: Ratio of Average Activity Duration (RAAD) — 1.223 ratio

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Feasibility of idle time exercise (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Marquette University
Primary completion: Feb 2025

Outcome Measures

Outcome	Result	p-value
PRIMARY Ratio of Average Activity Duration (RAAD)	1.223	—
PRIMARY System Usability Scale	80.1; 83.3	—
PRIMARY Intrinsic Motivation Inventory (IMI)	4.9; 5.4; 6.2; 6.0; 5.8; 2.8	—
PRIMARY Quebec User Evaluation of Satisfaction With Technology (QUEST)	4.52; 4.5	—

Summary

This project evaluates the feasibility of using custom wearable technology and associated procedures to increase activity of the more-involved upper extremity during the earliest stages of recovery from stroke by increasing the amount of therapeutic exercise during idle-time. The proposed research is relevant to public health because it takes steps to mitigate a significant problem in physical rehabilitation using low-cost technology to motivate and monitor idle-time exercise without adding significantly to clinician workloads. The project aligns with the NICHD / NCMRR Research Plan on Rehabilitation by exploiting a mobile health (mHealth) and sensor-based approach to promote health and wellness through participant-engaged, data-driven, individualized care.

Eligibility Criteria

Inclusion Criteria (General): The goal of this feasibility clinical trial is to assess the functional utility and subjective patient experience using a personal exercise cueing system designed to reduce learned non-use of the hemiparetic arm in the days, and weeks immediately following stroke. We therefore restrict inclusion to stroke survivors in the inpatient rehabilitation unit of Froedtert Memorial Hospital (Milwaukee, WI). Thus, candidate subjects will undergo screening by Dr. McGuire and his team prior to inclusion in the study. Stroke survivors shall have:

had a unilateral stroke within the last 30 days;
ability to give informed consent and be able to follow two-stage instructions;
a broad range of motor impairment as assessed using the upper extremity portion of the Fugl-Meyer Motor Assessment (i.e., UE-FM score <= 50 out of a possible 66);
age ≥ 18 yr. of age.

Exclusion Criteria (General) include:

Inability of subjects to give informed consent or follow two-stage instructions;
concurrent illness or severe pain limiting the capacity to conform to study requirements.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05900999). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.